Elevance Health Balance Sheet Health
Financial Health criteria checks 4/6
Elevance Health has a total shareholder equity of $42.6B and total debt of $30.0B, which brings its debt-to-equity ratio to 70.4%. Its total assets and total liabilities are $119.7B and $77.1B respectively. Elevance Health's EBIT is $9.1B making its interest coverage ratio 7.2. It has cash and short-term investments of $33.7B.
Key information
70.4%
Debt to equity ratio
US$30.00b
Debt
| Interest coverage ratio | 7.2x |
| Cash | US$33.65b |
| Equity | US$42.62b |
| Total liabilities | US$77.10b |
| Total assets | US$119.72b |
Recent financial health updates
Recent updates
Elevance Health: Carelon Growth Not Fully Appreciated
Apr 23Elevance Health (NYSE:ELV) Has More To Do To Multiply In Value Going Forward
Apr 15
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence
Apr 15Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Mar 13Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Feb 27Elevance Health (NYSE:ELV) Is Increasing Its Dividend To $1.71
Feb 18It's A Story Of Risk Vs Reward With Elevance Health, Inc. (NYSE:ELV)
Feb 10Elevance Health: Trading At Depressed Levels, So We Added Modestly
Jan 30Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71
Jan 26Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Jan 23Is There Now An Opportunity In Elevance Health, Inc. (NYSE:ELV)?
Jan 15
ELV Market Outlook
Jan 08This industry includes companies primarily engaged in providing health insurance products, managed care plans, and related healthcare services. These companies play a critical role in financing and maElevance Health Is An Undervalued Healthcare Juggernaut
Dec 26Returns Are Gaining Momentum At Elevance Health (NYSE:ELV)
Dec 15Elevance Health: A Quality Underpriced Stock Returning To Health
Dec 11Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 30We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve
Oct 29Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Oct 08Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07
Strategic Expansions and Investments Drive Growth and Diversify Revenue Streams
Mar 06Expansion in high-growth areas like infusible therapies through acquisitions aims to diversify income by servicing a broader client base.Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Financial Position Analysis
Short Term Liabilities: ELV's short term assets ($61.1B) exceed its short term liabilities ($42.7B).
Long Term Liabilities: ELV's short term assets ($61.1B) exceed its long term liabilities ($34.4B).
Debt to Equity History and Analysis
Debt Level: ELV has more cash than its total debt.
Reducing Debt: ELV's debt to equity ratio has increased from 68.4% to 70.4% over the past 5 years.
Debt Coverage: ELV's debt is not well covered by operating cash flow (16.2%).
Interest Coverage: ELV's interest payments on its debt are well covered by EBIT (7.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 01:04 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elevance Health, Inc. is covered by 48 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |